Trevi Therapeutics (NASDAQ:TRVI) Given New $24.00 Price Target at Needham & Company LLC
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) had its price target cut by stock analysts at Needham & Company LLC from $25.00 to $24.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would indicate a potential upside of 263.09% […]
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) had its price target cut by stock analysts at Needham & Company LLC from $25.00 to $24.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would indicate a potential upside of 263.09% […]
